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Abstract
Following a request from the European Commission, the Panel on Genetically Modiﬁed Organisms of
the European Food Safety Authority (GMO Panel) assessed the annual post-market environmental
monitoring (PMEM) report for the 2015 growing season of the Cry1Ab-expressing maize event
MON 810 provided by Monsanto Europe S.A. The GMO Panel concludes that the insect resistance
monitoring data submitted to EFSA do not indicate a decrease in susceptibility of ﬁeld Iberian
populations of corn borers to the Cry1Ab protein during the 2015 season. However, since the
methodology for insect resistance monitoring remained unchanged compared to previous PMEM
reports, the GMO Panel reiterates its previous recommendations on resistance monitoring to provide
sufﬁcient detection sensitivity. Although the farmer alert system to report complaints about product
performance could complement the information obtained from the laboratory bioassays, the GMO
Panel is currently not in a position to appraise its usefulness, and therefore encourages the consent
holder to provide more information on this complementary resistance monitoring tool. The data on
general surveillance (GS) do not indicate any unanticipated adverse effects on human and animal
health or the environment arising from the cultivation of maize MON 810. The GMO Panel reiterates its
previous recommendations on the analysis of farmer questionnaires, and advises the consent holder to
provide more detailed information on the conducting and reporting of the literature search in future
annual PMEM reports. Moreover, the GMO Panel encourages relevant parties to continue developing a
methodological framework to use existing networks in the broader context of environmental
monitoring. The GMO Panel concludes that the case-speciﬁc monitoring (CSM) and GS activities of
maize MON 810 as carried out by the consent holder do not provide evidence that would invalidate
previous GMO Panel evaluations on the safety of maize MON 810.
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Summary
Following a request from the European Commission, the Panel on Genetically Modiﬁed Organisms of
the European Food Safety Authority (GMO Panel) assessed the annual post-market environmental
monitoring (PMEM) report on the cultivation of the Cry1Ab-expressing maize event MON 810 during
the 2015 growing season provided by Monsanto Europe S.A.
The 2015 case-speciﬁc monitoring (CSM) data set on maize MON 810 consists of a survey on
compliance with non-Bacillus thuringiensis (non-Bt) refuges in Spain and Portugal, concentration–
response and diagnostic concentration bioassays to monitor for changes in susceptibility to the Cry1Ab
protein in target pests (European and Mediterranean corn borer) collected from Iberian populations,
and the outcome of the farmer alert system. The 2015 PMEM report shows partial compliance with the
implementation of non-Bt refuges in Spain as observed in previous years. Therefore, the GMO
Panel recommends that the consent holder consolidates its efforts to increase the level of compliance,
especially in regions of high maize MON 810 uptake, where such compliance is crucial to ensure the
effectiveness of the ‘high-dose/refuge’ strategy. The analyses of the bioassays do not indicate a
decrease in susceptibility to Cry1Ab in the tested target pests from the populations monitored in 2015.
The GMO Panel notes that the methodology for insect resistance monitoring remained unchanged
compared to previous PMEM reports and that the monitoring protocol adopted does not provide the
sufﬁcient sensitivity to detect early cases of resistance. The GMO Panel reiterates its previous
recommendations on resistance monitoring, in particular the recommendations to: (1) increase
sampling efforts and ensure that as many ﬁeld-collected larvae as possible are represented in the
laboratory assays as F1 larvae in order to provide sufﬁcient detection sensitivity (i.e. 3% resistance
allele frequency); and (2) implement annual monitoring of populations of both target pests exclusively
from north-east Iberia (i.e. the Ebro valley) where adoption rate of maize MON 810 is the highest in
the Iberian Peninsula and ﬁeld resistance to Cry1Ab is more likely to evolve.
The consent holder has implemented a farmer alert system allowing farmers to report complaints
about product performance (including unexpected ﬁeld plant damage caused by target pests).
Although this farmer alert system could complement the information received from the laboratory
bioassays, the GMO Panel is currently not in a position to appraise its usefulness, and therefore
encourages the consent holder to provide more information on this complementary resistance
monitoring tool. More information is required to determine whether appropriate communication
mechanisms and ﬁt-for-purpose educational programs are implemented that ensure the timely and
effective reporting of farmer complaints.
The 2015 general surveillance (GS) data set on maize MON 810 consists of a survey based on 261
farmer questionnaires, peer-reviewed publications relevant to the risk assessment and/or management
of maize MON 810 (published between June 2015 and May 2016). The available data do not indicate
any unanticipated adverse effects on human and animal health or the environment arising from the
cultivation of maize MON 810. Therefore, the GMO Panel considers that the GS activities of maize
MON 810 as carried out by the consent holder do not provide evidence that would invalidate previous
GMO Panel evaluations on the safety of maize MON 810.
No information collected from existing monitoring networks in the European Union (EU) was
provided by the consent holder. However, the GMO Panel notes that initiatives have been taken to
develop a methodological framework to use existing networks in the broader context of environmental
monitoring, and encourages relevant parties to continue to develop these.
Similar methodological shortcomings to those observed in previous annual PMEM reports on maize
MON 810 were identiﬁed in the analysis of farmer questionnaires, and the conducting and reporting of
the literature search. The GMO Panel therefore strongly reiterates its recommendations to provide
more detailed information on the sampling methodology and measures taken to reduce the possible
selection bias in farmer questionnaires. To improve the sampling frame of the farmer survey, the GMO
Panel reiterates the importance of operational national GMO cultivation registers and its recommendations
to consent holders to consider how they may make best use of the information recorded in national
registers and foster dialogue with those responsible for the administration of these registers where maize
MON 810 is cultivated.
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1. Introduction
The transformation event MON 810 has been introduced into a wide range of maize varieties that
have been cultivated in the European Union (EU) since 2003. Maize MON 810 produces the insecticidal
protein Cry1Ab from Bacillus thuringiensis (Bt), which confers resistance to certain lepidopteran pests,
such as the European corn borer (ECB), Ostrinia nubilalis (H€ubner) (Lepidoptera: Crambidae), and the
Mediterranean corn borer (MCB), Sesamia nonagrioides (Lefebvre) (Lepidoptera: Noctuidae). In 2015,
maize MON 810 was grown in Spain (107,749 ha), Portugal (8,017 ha), the Czech Republic (997 ha),
Slovakia (104 ha) and Romania (2.5 ha) over a total area of approximately 116,867 ha.1
According to Article 13 of Directive 2001/18/EC,2 each notiﬁcation for placing on the market of a
genetically modiﬁed organism (GMO) shall contain a plan for monitoring in accordance with Annex VII
of the Directive. Annex VII was supplemented by notes providing guidance on the objectives, general
principles and design of the monitoring plan.3
Results of post-market environmental monitoring (PMEM) activities on the cultivation of maize
MON 810 in the EU are reported to the European Commission and Member States on an annual basis
by Monsanto Europe S.A. (hereafter referred to as the consent holder). Since 2010, the Scientiﬁc
Panel on Genetically Modiﬁed Organisms of the European Food Safety Authority (hereafter referred to
as the GMO Panel) assesses these annual PMEM reports on the cultivation of maize MON 810 (EFSA
GMO Panel, 2011a, 2012a, 2013, 2014a, 2015a,b, 2016).
1.1. Background and Terms of Reference provided by the requestor
The marketing of maize MON 810 (notiﬁcation C/F/95/12-02) was authorised under Directive
90/220/EEC in the EU for all, other than food, uses by the Commission Decision 98/294/EC of
22 April 1998.4 Consent was granted to the consent holder on 3 August 1998 by the Competent
Authority of France. Food uses of maize derivatives were notiﬁed according to Article 5 of the Novel
Food Regulation (EC) No 258/97 on 6 February 1998. In July 2004, Monsanto notiﬁed MON 810 maize
seeds for cultivation, as existing products, according to Article 23 of Regulation (EC) No 1829/2003.
Following the request by the consent holder for the renewed market authorisation of maize
MON 810, the GMO Panel adopted a scientiﬁc opinion on the renewal applications submitted under
Regulation (EC) No 1829/2003 for: existing food and food ingredients produced from maize MON 810;
feed consisting of and/or containing maize MON 810, including the use of seed for cultivation; and
food and feed additives, and feed materials produced from maize MON 810 (EFSA, 2009). The GMO
Panel concluded that maize MON 810 is as safe as its conventional counterpart with respect to
potential effects on human and animal health, and that maize MON 810 is unlikely to have any
adverse effect on the environment in the context of its intended uses, especially if appropriate
management measures are put in place in order to mitigate possible exposure of non-target (NT)
Lepidoptera. The GMO Panel recommended that especially in areas of abundance of NT Lepidoptera
populations, the adoption of the cultivation of maize MON 810 be accompanied by management
measures in order to mitigate the possible exposure of these species to maize MON 810 pollen. In
addition, the GMO Panel advised that resistance management strategies continue to be employed and
that the evolution of resistance in lepidopteran target pests continues to be monitored, in order to
detect potential changes in resistance levels in pest populations (EFSA, 2009).
In the EU, a harmonised insect resistance management (IRM) plan (EuropaBio, 2012) for the single
lepidopteran-active Bt-maize events MON 810, Bt11 and 1507 is being implemented for the cultivation
of maize MON 810 since 2003. Implemented resistance management measures are based on the
‘high-dose/refuge’ strategy, and aim at delaying resistance evolution (Tabashnik et al., 2013). The
‘high-dose/refuge’ strategy prescribes planting Bt-crops that produce a very high concentration of the
insecticidal Bt-protein (25 times the amount needed to kill susceptible individuals (Gould, 1998)), so
that nearly all target insect pests that are heterozygous for resistance do not survive on it. In addition,
1 At present, maize MON 810 is the only GM maize event cultivated in the EU. Maize Bt176, also producing the protein Cry1Ab,
was cultivated in the EU between 1998 and 2005.
2 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the
environment of genetically modiﬁed organisms and repealing Council Directive 90/220/EEC. OJ L 106, 17.4.2001, pp. 1–39.
3 Council Decision 2002/811 of 3 October 2002 establishing guidance notes supplementing Annex VII to Directive 2001/18/EC of
the European Parliament and of the Council on the deliberate release into the environment of genetically modiﬁed organisms
and repealing Council Directive 90/220/EEC. OJ L 280, 18.10.2002, pp. 27–36.
4 Commission Decision of 22 April 1998 concerning the placing on the market of genetically modiﬁed maize (Zea mays L. line
MON 810), pursuant to Council Directive 90/220/EEC (98/294/EC). OJ L 131, 5.5.1998, pp. 32–33.
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a nearby structured refuge of the non-Bt-crop is required where the target insect pest does not
encounter the Bt-protein. In addition, resistance and compliance monitoring is conducted to allow the
periodic evaluation of the adequacy and efﬁcacy of the IRM strategy. Resistance monitoring is
designed to detect early warning signs indicating increases in tolerance of target pests in the ﬁeld; a
timely detection of such signs enables actions to limit the survival of resistant insects, and slow or
prevent their spread should resistance have evolved among ﬁeld populations.
In the context of annual PMEM reports on the cultivation of maize MON 810, the consent holder
follows a two-pronged approach for resistance monitoring: (1) monitoring for changes in susceptibility
to the Cry1Ab protein in ECB/MCB in laboratory bioassays and (2) monitoring of unexpected ﬁeld
damage caused by ECB/MCB through a farmer alert system.
From 2005 onwards, the consent holder submitted to the European Commission PMEM reports on
the cultivation of maize MON 810 according to the provisions of Directive 2001/18/EC. These annual
PMEM reports are composed of case-speciﬁc monitoring (CSM), which focuses on resistance and
compliance monitoring to allow the periodic evaluation of the adequacy and efﬁcacy of the IRM
strategy, and general surveillance (GS), which focuses on detecting unanticipated adverse effects
caused by the cultivation of maize MON 810.
Since 2010, the European Commission requested the GMO Panel to assess the annual PMEM
reports on the cultivation of maize MON 810. The GMO Panel therefore adopted scientiﬁc opinions on
the 2009 to 2014 annual PMEM reports (EFSA GMO Panel, 2011a, 2012a, 2013, 2014a, 2015a,b,
2016). From the data provided in the previous annual PMEM reports, the GMO Panel did not identify
adverse effects on human and animal health and the environment resulting from the cultivation of
maize MON 810. However, the GMO Panel noted shortcomings in the methodology for CSM and GS,
and made several recommendations to improve future annual PMEM reports on maize MON 810.
On 22 May 2012, the European Commission requested the European Food Safety Authority (EFSA)
to compile an inventory of existing environmental surveillance networks at European and national
level, and develop a set of assessment criteria to support the selection of such networks for PMEM of
genetically modiﬁed (GM) plants. Following this request, EFSA’s Assessment and Methodological
Support Unit (hereafter referred to as AMU Unit) commissioned an external report that: reviewed
statistical methods used in the analysis of ecological and environmental data sets; provided an
inventory of statistical approaches in ecological and environmental monitoring and identiﬁcation of
data requirements for the items in the inventory; delivered an inventory of European, National and
Regional existing surveillance networks/programmes; and gave recommendations of the most
appropriate analysis methodologies for PMEM of agro-ecosystems (Centre for Ecology and Hydrology,
Perseus et al., 2014). In this external report and other publications (e.g. Smets et al., 2014), several
existing networks were identiﬁed as potentially suitable for GS of GM plants, although their usefulness
is limited due to issues pertaining to data accessibility, data reporting format, and data connectivity
with GMO registers (EFSA GMO Panel, 2014b).
On 24 March 2015, the European Commission requested EFSA to assess the concerns raised by the
consent holder about the GMO Panel recommendations on the IRM strategy for maize MON 810.5
EFSA concluded that the previous conclusions and recommendations by the GMO Panel remain valid
(EFSA, 2015).
On 18 December 2015, the National Committee of Biosafety of the Spanish Competent Authority
supplied several considerations about EFSA’s recommendations on the IRM plan for maize MON 810.6
In two 2016 Technical Reports (EFSA, 2016a,b), following the requests of the European
Commission,7,8 EFSA assessed the implications of new relevant scientiﬁc publications by Bøhn et al.
(2016) and Hofmann et al. (2016) for the environmental risk assessment (ERA) of maize MON 810 for
cultivation. EFSA considered that conclusions and risk management recommendations previously made
by the GMO Panel remain valid and applicable.
In another 2016 Technical Report (EFSA, 2016c), EFSA assessed the available scientiﬁc information
on teosinte for its relevance for the ERA of maize MON 810 for cultivation, as requested by the
European Commission.9 The presence of teosinte in the EU has been reported in maize ﬁelds in Spain
(in the Ebro Valley (Aragon) and in the region of Catalu~na in the summer of 2014) and, to a lesser
5 http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2015-00235
6 http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2015-00650
7 http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2016-00390
8 http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2016-00389
9 http://registerofquestions.efsa.europa.eu/roqFrontend/questionDocumentsLoader?question=EFSA-Q-2016-00388
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extent, in France (in the region of Poitou-Charentes since 1990). Pathways to harm from the
cultivation of maize MON 810 were hypothesised for situations where maize MON 810 and teosinte
would grow sympatrically, focusing on speciﬁc areas of risk typically considered in ERAs of GM plants.
For each of these pathways, it is unlikely that environmental harm will be realised. EFSA therefore
concluded that there are no data that indicate the necessity to revise the previous ERA conclusions
and risk management recommendations for maize MON 810 made by the GMO Panel.
On 1 September 2016, the European Commission received from the consent holder the annual
PMEM report for the 2015 cultivation season of maize MON 810 (hereafter referred to as 2015 PMEM
report).10
On 13 October 2016, the European Commission requested the GMO Panel to assess the 2015
PMEM report and, in particular, to evaluate the ﬁndings of the monitoring activities, taking into
consideration the comments received from Member States and to assess the appropriateness of the
methodology if this is found to differ compared to the previous season.
On 17 January 2017, the European Commission asked the consent holder to provide additional
information to assess the 2015 PMEM report upon EFSA request. The requested information was
received on 6 February 2017.
On 7 February 2017, EFSA held an applicant’s hearing to which the consent holder participated as a
hearing expert of the PMEM Working Group and provided clariﬁcations on the methodology of the
monitoring activities followed in the 2015 PMEM report.11
On 20 March 2017, the European Commission sent an updated version of the 2015 PMEM report
and asked the GMO Panel to take it into consideration in the adoption of the Scientiﬁc Opinion.
2. Data and methodologies
2.1. Data
In delivering this scientiﬁc opinion, the GMO Panel took into account the data set derived from the
CSM and GS activities performed by the consent holder:
• The IRM plan consisting of: (1) the ‘high-dose/refuge’ strategy, including surveys on farmers
compliance with non-Bt-maize refuges; (2) ﬁeld monitoring and laboratory assays to measure
changes in baseline susceptibility to the Cry1Ab protein in target pest populations12; (3) a
communication and education plan of farmers; (4) a remedial action plan in the event of any
conﬁrmed evolution of pest resistance13;
• the outcome of the farmer alert system;
• a survey based on 261 questionnaires received from farmers in the main two countries
growing maize MON 810: 212 in Spain and 49 in Portugal14;
• company stewardship activities and technical user guides15;
• an assessment of 18 peer-reviewed scientiﬁc studies relevant to the risk assessment
and/or management of maize MON 810, which were published between June 2015 and
May 2016.16
The additional information provided by the consent holder on 6 February 2017 following a request
from EFSA was also considered.
2.2. Methodologies
The GMO Panel conducted a scientiﬁc assessment on the data submitted in the context of the
annual 2015 PMEM report, in accordance with Annex VII to Directive 2001/18/EC. Following the terms
of reference of the European Commission mandate, the GMO Panel also considered whether the
methodology applied in the monitoring activities during the 2015 growing season differed from that
followed in the previous PMEM reports on maize MON 810.
10 http://ec.europa.eu/food/plant/gmo/reports_studies_en
11 http://www.efsa.europa.eu/sites/default/files/gmopmemreports2017.pdf
12 2015 PMEM report, Appendices 7 and 8.
13 2015 PMEM report, Appendix 6. More details on the key elements of the IRM plan are described in EFSA GMO Panel (2011a).
14 2015 PMEM report, Appendix 1.
15 2015 PMEM report, Appendices 3.1–3.5.
16 2015 PMEM report, Appendices 5.1–5.4.
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The GMO Panel took into account the principles and requirements described in its guidance on the
PMEM of GM plants (EFSA GMO Panel, 2011b), and EFSA’s guidance on the application of systematic
review methodology to food/feed safety assessments to support decision-making (EFSA, 2010).
The comments raised by Member States were taken into consideration during the assessment of
the 2015 PMEM report and the development of this scientiﬁc opinion.17
3. Assessment
3.1. Implementation of non-Bt-maize refuges
Compliance with refuge requirements and the implementation of the operational details of the IRM
plan were assessed through the farmer questionnaires supplied as part of GS. The consent holder
asked 212 farmers from Spain and 49 farmers from Portugal, the two main EU countries where maize
MON 810 was cultivated in 2015 (i.e. approximately 99% of the maize MON 810 area in the EU), to
complete a questionnaire which included a question on compliance with the refuge strategy.
In Spain, 200 farmers growing maize MON 810 complied with refuge requirements. Thirty-eight of
those farmers (18% of the farmers surveyed) were not required to plant a refuge because the area of
maize MON 810 was less than 5 ha (Appendix A). The 12 farmers that did not plant a refuge but
cultivated an area of maize MON 810 of more than 5 ha provided the following two main reasons for
their non-compliance (as indicated in the survey): (1) corn borers cause harvest losses in conventional
maize (eight farmers); and (2) the implementation of refuges complicates the sowing (four farmers).
The consent holder did not provide the exact location of the Bt-maize ﬁelds where no refuges were
planted.
In Portugal, the four farmers that did not plant a refuge reported that they were part of a
‘production area’ which had made refuge arrangements to ensure refuge compliance, while the other
45 maize MON 810-growing farmers surveyed complied with the refuge requirements (none of them
were exempted since the maize MON 810 area was more than 5 ha). In addition to the farmer
questionnaires, the Portuguese authorities performed inspections at 66 farms (out of the 216
notiﬁcations received in 2015) where maize MON 810 was grown to check compliance with refuge and
coexistence requirements outlined in Portuguese law. Based on these inspections, the Portuguese
authorities concluded that there was full compliance with refuge requirements.
GMO Panel assessment
The 2015 PMEM report shows full compliance with refuge requirements in Portugal and partial
compliance (93%) in Spain as observed in previous years (Appendix A). As pointed out by Tabashnik
et al. (2013), Casta~nera et al. (2016) and others, refuge compliance is crucial to sustain the efﬁciency
of the technology and delay resistance evolution, especially in regions of high adoption rate (i.e.
> 60%).18 The GMO Panel considers that there should be full compliance in high adoption areas.
Therefore, the GMO Panel reiterates that the consent holder should strive to increase the level of
compliance in those areas.
The GMO Panel reminds that the refuge requirements also apply to clusters of small maize
MON 810 ﬁelds (i.e. a group of adjacent ﬁelds that can be from different farms) in which the
aggregate area planted with maize MON 810 is greater than 5 ha.19 The GMO Panel recommends the
consent holder and Member States to develop appropriate information systems on GM crop cultivation.
17 Comments were received from Austria, Germany, Hungary, Italy, the Netherlands, Romania and Spain.
18 The adoption rate of maize MON 810 is expressed as a fraction of total maize cultivation in the same geographical area (i.e.
geographical zone where maize is typically grown following similar agronomic practices isolated from other maize areas by
barriers that might impair an easy exchange of target pests between those areas).
19 When cultivating maize MON 810, the presence of refuge areas equivalent to at least 20% of the surface planted with maize
MON 810, should be ensured when a single ﬁeld cropped to maize MON 810 is larger than 5 ha, and when a cluster of
adjacent ﬁelds cropped to maize MON 810 has an aggregated surface greater than 5 ha, irrespective of individual ﬁeld and
farm size (EFSA, 2009).
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3.2. Resistance monitoring of target pests
3.2.1. Changes in baseline susceptibility to Cry1Ab in corn borers
3.2.1.1. Field sampling of ECB/MCB populations
For the 2015 resistance monitoring activities, ECB and MCB larvae were collected at the end of the
maize-growing season from corn borer populations20 found in refuges and conventional maize ﬁelds
adjacent to maize MON 810 ﬁelds (hereafter also referred to as sampling sites) occurring in two
different geographical areas of the Iberian Peninsula: north-east and central for ECB, and north-east
for MCB. Samples collected in 2015 included corn borer populations from north-east, which is the area
with the highest adoption rate of maize MON 810 in the Iberian Peninsula (Appendix B), and therefore
with the highest selection pressure (and thus where ﬁeld resistance is more likely to evolve).
For ECB, 376 and 443 last-instars were collected from three ﬁelds in north-east and three ﬁelds in
central Iberia, respectively (Table 1). Two and four additional sites were sampled in each area, but the
minimum number of 100 larvae established in the harmonised IRM plan was not found. A total of 152
and 180 larvae reached the adult stage (40% and 41% of the ﬁeld-collected larvae) and were placed
in 10 and 9 oviposition cages. All cages were used for mating to obtain F1 larvae for the bioassays.
For MCB, 529 last-instars were collected from three ﬁelds in north-east Iberia (Table 1). In the
laboratory, 444 of the ﬁeld-collected larvae reached the adult stage (16% pre-imaginal mortality) and
were placed in 28 oviposition cages for mating. Of those, 12 oviposition cages, containing a total of 195
adults (37% of the number of ﬁeld-collected larvae), were used to obtain F1 larvae for the bioassays.
For both species, emerging adults from the different sampling sites of a given geographical area
were pooled for mating.
3.2.1.2. Insect bioassays
Concentration–response assays and diagnostic concentration assays21 were conducted to assess the
susceptibility of the ECB and MCB populations collected in 2015 to the Cry1Ab protein, and to monitor
possible changes in baseline susceptibility. In both assays, neonate larvae of the subsequent
Table 1: Field collection of Ostrinia nubilalis (ECB) and Sesamia nonagrioides (MCB) larvae in the
2015 growing season in different areas of the Iberian Peninsula
Target pest Geographical area Sampling site (Province)
No. larvae
collected
ECB North-east Iberia(a) Alberuela de Tubo (Huesca) 132
Candasnos (Huesca) 144
Melida (Navarra) 100
Total 376
Central Iberia(b) La Herrera (Albacete) 106
Motilleja (Albacete) 178
Santa Ana (Albacete) 159
Total 443
MCB North-east Iberia Alberuela de Tubo (Huesca) 107
Candasnos (Huesca) 162
Beire (Navarra) 260
Total 529
Larvae were collected between 7 and 8 September 2015 from central Iberia and between 21 and 23 September 2015 from
north-east Iberia. Geographical coordinates were not provided for the sampling sites. All ECB larvae collected were in diapause,
while most of the MCB larvae collected were not.
(a): Two additional sites were inspected but did not yield sufﬁcient larvae for further analysis.
(b): Four additional sites were inspected but did not yield sufﬁcient larvae for further analysis.
20 The term population is referred in the present opinion to those corn borers sampled in a given geographical area (i.e. north-
east and central Iberia).
21 The terminology used to refer to the laboratory bioassays (i.e. concentration–response and diagnostic concentration) in the
present opinion is different to that used by the consent holder (i.e. dose–response and diagnostic dose). Since the actual
amount of Cry1Ab ingested by the tested larvae was not measured and, therefore, actual doses of Cry1Ab could not be
estimated, the GMO Panel considers that the term concentration is more precise.
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generation (F1 larvae) were used. The neonates were exposed to puriﬁed Cry1Ab protein in artiﬁcial-
diet overlay assays.22 In addition, a conﬁrmatory experiment with leaves of maize MON 810 was used
to check the absence of resistant individuals in the progenies obtained from ﬁeld-collected larvae.
Raw data of the insect bioassays were not made available by the consent holder even following a
speciﬁc request by EFSA on 17 January 2017.
Concentration–response bioassays
Methodology
Eight concentrations, ranging from 0.2 to 28.22 ng Cry1Ab/cm2, and seven to ten concentrations,
ranging from 1 to 128 ng Cry1Ab/cm2, and a negative control (i.e. the same buffer solution in which
the puriﬁed Cry1Ab protein was dissolved) were tested for the ECB and MCB populations, respectively.
The concentration of 28.22 ng Cry1Ab/cm2 was also used as the diagnostic concentration for ECB
testing for resistance. In all bioassays, three replicates were used for each concentration and the
control, each one consisting of 32 larvae (64 for the controls), giving a total of 96 larvae tested for
each concentration (192 for the controls). Mortality and moult inhibition was assessed after seven days
of exposure.23 Moulting inhibition concentration for 50% (MIC50) and 90% (MIC90) values, with a 95%
conﬁdence interval (CI), were estimated by probit analysis (Robertson et al., 2007).
The susceptibility of the ECB and MCB laboratory reference strains to Cry1Ab was assessed in the
same manner as described above.24
Resistance ratios (RR) of ﬁeld populations with 95% CI were calculated with respect to the MIC50
and MIC90 values obtained for the reference laboratory strains.
25 Moulting inhibition concentrations of
the ﬁeld-collected populations were considered signiﬁcantly different with respect to the respective
laboratory reference strain if the 95% CI values for the RR MIC50,90 did not include 1.
Results
A concentration–response was not observed for any of the ECB populations tested and,
consequently, 50% and 90% lethal concentration (LC50 and LC90) values were not estimated. The
consent holder indicated that it is not uncommon to see Bt-susceptible insects survive the duration of
the assay by feeding minimally or not at all (. . .) because Bt proteins have anti-feedant properties and
the conditions under which such assays are run are relatively benign. LC50 and LC90 values were not
provided for the MCB population collected in 2015.
Moulting inhibition (mean  standard deviation) in the control groups was 2.1  3.6% and
3.1  1.6% for the ECB populations of north-east and central Iberia, and 7.4  2.7% for the MCB
population.
The MIC50 and MIC90 values estimated for the ECB and MCB populations tested in 2015 are given
in Table 2 and Table 3, respectively. The MIC50 and MIC90 values are in the range of those reported in
previous years.
Signiﬁcant differences in MIC50 were observed between the ﬁeld-collected ECB and MCB populations
and their respective susceptible laboratory reference strains due to a decrease in susceptibility of the
latter compared to previous seasons (Appendix C). The consent holder indicated that the decrease in
susceptibility of the lab population could be due to variations that occur in laboratory-reared insects
produced by a variety of reasons. Regarding the susceptibility of the ﬁeld-collected ECB and MCB
populations, the consent holder concluded that differences found in the susceptibility to the toxin are
within the range of variability expected for ﬁeld collections of these corn borers. Further, the analyses
of historical series of susceptibility data of S. nonagrioides or O. nubilalis to Cry1Ab did not reveal signs
of changed susceptibility to this toxin by ﬁeld collections from the sampling the [sic] areas considered.
22 For the bioassays with ECB larvae, batch 2a was used (1.6 mg Cry1Ab/mL in 50 mM sodium bicarbonate buffer, pH 10.25,
91% purity). For the bioassay with MCB larvae, batch B3 was used (1.8 mg Cry1Ab/mL in 50 mM sodium bicarbonate buffer,
pH 10.25, 91% purity).
23 Mortality is deﬁned as larvae not showing any reaction when prodded whereas moulting inhibition is deﬁned as larvae that
either have died or not moult to the second instar after 7 days.
24 ECB strains were established from larvae collected from Niedernberg (Germany) in 2002 and from 145 larvae collected from
Galicia (Spain) in 2015. The MCB strain was established from larvae collected from Andalucıa (661 larvae), Madrid (793 larvae),
Ebro (857 larvae) and Galicia (665 larvae) (Spain) in 1998 (Gonzalez-Nu~nez et al., 2000). To preserve its vigour, the MCB strain
was refreshed periodically with new individuals. To this end, the progenies of the populations collected for the monitoring
bioassays are used, and between 10% and 15% of new individuals with respect to the laboratory strain are introduced. ECB
strains have not been refreshed yet. The similarity in susceptibility is veriﬁed before the introduction of new individuals.
25 In the 2015 PMEM report, RR for ECB and MCB were calculated differently: for ECB, RR = MIC laboratory reference strain/MIC
ﬁeld-collected population; for MCB, RR = MIC ﬁeld-collected population/MIC laboratory reference strain.
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Diagnostic concentration assays
Methodology
A diagnostic concentration assay was performed with the MCB population collected in 2015 using a
concentration of 726 ng Cry1Ab/cm2.26 The highest concentration of the concentration–response
bioassay (28.22 ng Cry1Ab/cm2) was used as the diagnostic concentration for the ECB ﬁeld
Table 2: Historical data of susceptibility to the puriﬁed Cry1Ab protein of North East and Central Iberian ﬁeld
populations of Ostrinia nubilalis (ECB) collected in refuge areas and/or conventional maize ﬁelds adjacent to
maize MON 810 ﬁelds
Population Season
No. larvae
collected
(no. of sites)
Protein
batch(a)
MIC50
(95% CI)(b)
MIC90
(95% CI)(b)
RR MIC50
(c) RR MIC90
(c)
North-east
Iberia
2008 401 (4) 1 7.03 (4.89–10.03) 23.91 (15.76–46.84) 3.11/3.18*,(d) 2.93/5.35*,(d)
2009 509 (3) 1 6.40 (5.32–7.75) 13.68 (10.77–20.02) 1.75* 1.43
2011 382 (6) 2 1.79 (1.54–2.07) 4.19 (3.45–5.48) 0.61* 0.67
2013 452 (3) 2a 2.48 (2.03–3.02) 5.41 (4.27–7.61) 1.26 0.82
2015 376 (3) 2a 2.12 (1.75–2.55) 5.43 (4.36–7.29) 0.53* 0.77
Central
Iberia
2009 396 (2) 1 3.09 (2.03–4.33) 11.98 (8.12–22.31) 0.85 1.25
2011 404 (3) 2 1.56 (1.27–1.91) 4.04 (3.12–5.91) 0.53* 0.64
2013 432 (2) 2a 2.40 (2.04–2.83) 6.38 (5.18–8.34) 1.22 0.97
2015 443 (3) 2a 1.88 (1.68–2.11) 3.38 (2.91–4.21) 0.47* 0.48*
*Signiﬁcant difference (p < 0.05) between the ﬁeld population and the reference laboratory strain was identiﬁed for that season.
(a): Data provided by the consent holder in previous monitoring reports showed that the Cry1Ab protein batches 1 and 2, and Protein batches 2 and 2a
have similar insecticidal activity (see Appendix C).
(b): 50% and 90% moulting inhibition concentration (MIC50 and MIC90) and their 95% conﬁdence intervals (CI 95%) are expressed in ng Cry1Ab/cm
2.
(c): Resistance ratio (RR) between MIC values of the ﬁeld-collected populations and the reference laboratory strain for each cultivation season. RR were
calculated by EFSA since the consent holder calculated them differently (i.e. RR = MIC reference laboratory strain/MIC ﬁeld-collected population).
(d): The laboratory reference strain was tested two times in 2008 (see Appendix C).
Table 3: Historical data of susceptibility to the puriﬁed Cry1Ab protein of North East Iberian ﬁeld populations of
Sesamia nonagrioides (MCB) collected in refuge areas and/or conventional maize ﬁelds adjacent to maize
MON 810 ﬁelds
Population Season
No. larvae
collected
(no. of sites)
Protein
batch(a)
MIC50
(95% CI)(b)
MIC90
(95% CI)(b)
RR MIC50
(95% CI)(c)
RR MIC90
(95% CI)(c)
North-east Iberia 2005 400 (2) B1 9 (3–15) 76 (54–117) 0.5 (NR)(d) 0.8 (NR)(d)
2007 457 (3) B1 14 (8–20) 99 (71–158) 0.9 (NR) 1.0 (NR)
2009 489 (3) B1 22 (16–28) 188 (138–277) 1.1 (0.8–1.7) 1.6 (NR)
2011 564 (4) B2 20 (14–27) 135 (91–232) 2.2 (1.6–3.0)* 2.0 (1.3–2.9)*
2013 742 (5) B2 19 (14–25) 163 (108–287) 2.6 (2.0–3.4)* 3.4 (2.2–5.2)*
2015 529 (3) B3 17 (13–21) 84 (63–124) 0.6 (0.5–0.8)* 1.3 (0.9–1.8)
NR: not reported.
*Signiﬁcant difference (p <0.05) between the ﬁeld population and the reference laboratory strain was identiﬁed for that season.
(a): Data provided by the consent holder in previous monitoring reports showed that the Cry1Ab protein batches B1 and B2, and B2 and B3 have
similar insecticidal activity (see Appendix C).
(b): 50% and 90% moulting inhibition concentration (MIC50 and MIC90) and their 95% conﬁdence intervals (CI 95%) are expressed in ng Cry1Ab/cm
2.
(c): Resistance ratio (RR) between MIC values of the ﬁeld-collected populations and of the susceptible laboratory strain for each cultivation season.
(d): MIC50 and MIC90 values of the laboratory reference strain used to calculate RR MIC50 and RR MIC90 correspond to those estimated in 2004.
26 The diagnostic concentration for ECB was established by pooling data from populations collected in the Czech Republic,
France, Germany, Italy, Hungary, Poland, Portugal, Romania and Spain between 2005 and 2012. This resulted in a MIC99 value
of 48.2 (42.8–55.1) ng Cry1Ab/cm2. Due to a change in the protein batch in 2012, the diagnostic concentration was
re-calibrated, resulting in a MIC99 value of 28.22 ng Cry1Ab/cm
2. The diagnostic concentration for MCB was established by
pooling data from populations collected in north-east, central and south-west between 2008 and 2012. This resulted in a
MIC99 value of 726 (548–1013) ng Cry1Ab/cm
2.
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populations collected in 2015. For both species, three replicates were used, each one consisting of
32 larvae, giving a total of 96 larvae tested. The negative controls were the same as for the
concentration–response bioassays. Moult inhibition was assessed after seven days.
Results
Table 4 shows the results of the diagnostic concentration assays with ECB and MCB populations.
Moult inhibition of ECB larvae collected in north-east and central Iberia, and MCB larvae collected in
north-east Iberia in 2015, was 100% since no single larvae survived after 7 days of exposure.
Conﬁrmatory experiment with maize MON 810 leaves
Methodology
The survival of the four ECB larvae that survived the concentration–response bioassay at a
concentration of 14.1 and 20 ng Cry1Ab/cm2 (two larvae for each concentration), all surviving MCB
larvae from the concentration–response assay (574 larvae), and the approximate 1,400 MCB F1 larvae
that were not used in the bioassays was tested in a conﬁrmatory experiment with maize MON 810
leaves. Larvae were fed maize MON 810 leaves ad libitum. No negative control treatments (i.e. larvae
fed near-isogenic maize leaves) were used.
Results
None of the ECB and MCB larvae fed maize MON 810 leaves survived.
GMO Panel assessment
Changes in the methodology compared with the 2014 PMEM report were not identiﬁed. Consistent
with its previous recommendations, the GMO Panel acknowledges that the consent holder has
provided further details on the laboratory rearing of corn borers, the reference laboratory strains and
the methodology of the bioassays (EFSA GMO Panel, 2016). To evaluate and verify data quality, and to
be in a position to fully assess the analysis of the laboratory assays performed with the progeny of the
corn borers sampled, the consent holder should provide the raw data in future PMEM reports.
To ensure the timely implementation of remedial measures, the GMO Panel previously
recommended that a detection level of 3% resistance allele frequency in target pest populations is the
maximum level that should be achieved in practice (for further details, see EFSA, 2015 and EFSA GMO
Panel, 2016). Between 152 and 195 emerging adults were placed in oviposition cages to obtain F1
larvae for the susceptibility bioassays (representing between 32% and 38% of the ﬁeld-collected
larvae), and only 96 F1 larvae were ﬁnally used in the diagnostic concentration assay (for instance, see
Marcon et al., 2000 and Alcantara et al., 2011). This implies that a maximum of 192 alleles were
tested for each population (i.e. two alleles per larvae, assuming that no siblings were tested), and
therefore, the actual limit of resistance allele frequency that could be detected with the methodology
used in the diagnostic concentration assay in 2015 was above the targeted threshold (for further
details, see Roush and Miller, 1986 and Andow and Ives, 2002). The GMO Panel acknowledges that
Table 4: Moulting inhibition of north-east and central Iberian ﬁeld populations of Ostrinia nubilalis
(ECB) and Sesamia nonagrioides (MCB) tested with a diagnostic concentration of Cry1Ab
Species Population Season
Protein
batch(a)
Moulting
inhibition
(%  SE)
ECB North-east Iberia 2013 2a 100
2015 2a 100
Central Iberia 2013 2a 100
2015 2a 100
MCB North-east Iberia 2013 B2 97  2
2015 B3 100
Diagnostic concentration is deﬁned as the concentration causing 99% of moulting inhibition to ﬁrst instars. The diagnostic
concentration was 28.22 ng Cry1Ab/cm2 for ECB populations and 726 ng Cry1Ab/cm2 for MCB. For both species, three replicates
were used, each one consisting of 32 larvae, giving a total of 96 larvae tested.
SE: standard error.
(a): Data provided by the consent holder in previous monitoring reports showed that the Cry1Ab protein batches B2 and B3 have
similar insecticidal activity (see Appendix C).
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several limitations exist for sampling adequate numbers of target pests in the ﬁelds to reach the
targeted threshold, but encourages the consent holder to increase sampling efforts, and ensure that as
many ﬁeld-collected larvae as possible are represented in the laboratory assays as F1 larvae in order to
provide sufﬁcient detection sensitivity.
The GMO Panel has previously recommended focusing the monitoring activities in north-east Iberia
(i.e. the Ebro valley), where adoption rates of maize MON 810 are the highest in the Iberian Peninsula
(Appendix B), and where ﬁeld resistance to Cry1Ab is more likely to evolve. Within the Ebro valley,
ECB and MCB larvae should be collected from at least three sampling zones of approximately
10 km 9 10 km, where adoption rate of maize MON 810 is higher than 60% for at least three
consecutive years (EFSA, 2015). Since information on the adoption rate of maize MON 810 is only
available at the province level, the GMO Panel is not in a position to assess what has been the actual
selection pressure in the vicinity of sampled ﬁelds over the last years. The GMO Panel therefore
recommends the consent holder and Member States to develop appropriate information systems on
GM crop cultivation and invites the consent holder to report estimates of historical adoption rates in
the vicinity (e.g. comarcas, municipalities) of ﬁelds that were sampled.
In the 2015 PMEM report, only MIC values were provided for MCB and ECB. For ECB, LC values
could not be estimated because a concentration–response was not observed (see Section 3.2.2). The
consent holder claimed that it might be due to antifeeding properties of Bt-proteins but did not provide
any evidence supporting this assumption. The GMO Panel agrees that measurements of sublethal
effects proved in some cases to be more sensitive than mortality for natural toxins (e.g. Schmutterer,
1990), including Bt-proteins (e.g. Lovei et al., 2009). However, both lethal and sublethal
measurements provide useful information for detecting possible adverse effects. Therefore, the GMO
Panel reiterates its previous recommendation to report both LC and MIC values for ECB and MCB in
future PMEM reports (EFSA GMO Panel, 2012a).
The MCB laboratory reference strain has been periodically refreshed with larvae collected from the
same sampling zones as for the monitoring activities. It is likely that some of the individuals of the
strain were subjected to selection pressure, therefore affecting the value of resistance ratios to
measure changes in susceptibility to Cry1Ab. If refreshment of laboratory reference strains is needed,
individuals should be collected from areas where Cry1-expressing maize is not grown.
The conﬁrmatory experiment with maize MON 810 leaves was used to further test for the absence
of resistant individuals in the progenies obtained from ﬁeld-collected larvae as maize MON 810 is
expected to cause 100% mortality of heterozygotes. However, since there were no negative controls
(i.e. larvae fed with near-isogenic maize leaves), these conﬁrmatory tests cannot be used to reinforce
the bioassays with puriﬁed Cry1Ab as uncertainty remains on the suitability of the test system and the
reliability of the obtained results (Romeis et al., 2011). Moreover, further information (e.g. 50% lethal
time (LT50), developmental stage at death, Cry1Ab protein expression in detached leaves, would be
needed to correctly interpret the results.
3.2.1.3. Farmer alert system
The consent holder has implemented a farmer alert system allowing farmers to report complaints
about product performance (including unexpected crop damage caused by target pests).
The consent holder stated that, during the 2015 cultivation season, more than 300 complaints were
received and assessed. None of these complaints were related to infestation of maize MON 810 by
corn borers.
Although this farmer alert system could be a useful complement to the information received from
the laboratory bioassays, the GMO Panel is currently not in a position to appraise its usefulness, and
therefore encourages the consent holder to provide more information on this complementary
resistance monitoring tool. More information is required to determine whether appropriate
communication mechanisms and ﬁt-for-purpose educational programs (e.g. characterisation of the
damage caused by corn borers) are implemented ensuring the timely and effective reporting of farmer
complaints.
3.2.2. Conclusions on resistance monitoring of target pests
The analyses of the data set provided by the consent holder do not indicate a decrease in
susceptibility to the Cry1Ab protein of the corn borer samples tested in the 2015 cultivation season.
However, the GMO Panel is of the opinion that, due to the low number of ﬁeld ECB and MCB
genotypes tested, there is not enough power to assess whether the frequency of resistance alleles is
actually below the targeted threshold of 3%.
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3.3. Farmer questionnaires
In its annual 2015 PMEM report, the consent holder submitted a survey completed between
December 2015 and February 2016 based on 261 questionnaires received from farmers in two
European countries: 212 in Spain and 49 in Portugal (Table 5). No farmers from the Czech Republic,
Romania and Slovakia, representing approximately 1% of the maize MON 810 grown in the EU in
2015, were interviewed. The consent holder concluded that the analysis of the questionnaires did not
identify any potential adverse effects that might be related to MON 810 plants and their cultivation.
The methodology of the farmer questionnaires to identify unanticipated adverse effects caused by
the cultivation of maize MON 810 was similar to that in previous annual PMEM reports (EFSA GMO
Panel, 2011a, 2012a, 2013, 2014a, 2015b, 2016). In the assessment that follows, some important
observations and comments on the farmer questionnaire survey are offered. Additional ones can be
found in Annex A of EFSA GMO Panel (2016).
GMO Panel assessment
The GMO Panel makes the following observations and comments on the methods and results of the
farmer questionnaire survey:
• The farmer questionnaires survey should ideally aim to collect responses relating to areas of
actual maize MON 810 cultivation. However, it is stated that the sampling frame for this survey
cannot be based on the total population of ﬁelds with MON 810 cultivation in Europe, and so
farmers are sampled instead of ﬁelds. As the farmer questionnaires survey currently targets
the population of European farmers growing maize MON 810, it should be conducted on a
representative sample of that population. Survey design methodology requires the use of a
sampling frame which is representative for the sampled target populations and that the
random selection process is applied to the sample units in the sampling frame prior to
proceeding with the interviews. In the annual 2015 PMEM report, it is not clear whether such
sampling frames were used since it is indicated that GMO cultivation register information –
where publicly available – is used to identify the regions of cultivation. It cannot not be used to
identify the cultivating farmers since in most countries the personal data of farmers are not
freely available and Farmers therefore are selected from customer lists of the seed selling
companies or interviewer companies, plus experience from previous surveys or search in the
region. Therefore, it cannot be ascertained that the selected farmers (from Portugal and Spain)
are representative of the target farmer population. Additionally, it is unclear whether the
current sampling strategy does take into account farmers growing maize MON 810 varieties
bought from other companies. The GMO panel advises that the sampling frame used should
take account of all maize MON 810 varieties cultivated in the EU.
• For the reasons stated above, the claim The whole sampling procedure ensures that the
monitoring area will be proportional to and representative of the total regional area under GM
cultivation cannot be substantiated, based on the information provided in the report. The
selection procedure, reportedly gives emphasis on areas of high adoption of MON 810;
however, it is not completely clear how this is done. The consent holder should clearly describe
how the number of farmers sampled by country/area per year is calculated and how the results
of these calculations ensure that areas of intensive maize MON 810 cultivation are appropriately
represented in the survey. A description of the method to ensure that units are randomly
Table 5: Farmers surveyed and maize MON 810 areas monitored in 2015 through questionnaires
Country
No. of
farmers
surveyed
Mean maize MON
810 area monitored
per farmer (ha)
Monitored
maize MON
810 area (ha)
Total planted
MON 810
area (ha)
Monitored
maize MON 810
(% of total area)
Spain 212(a) 26 5,466 107,749 5.1
Portugal 49(b) 66 3,251 8,017 40.5
Farmers from the Czech Republic, Slovakia and Romania, representing approximately 1% of the cultivated area of maize
MON 810 in the EU, were not surveyed.
(a): Eighty-six farmers were from Aragon, 61 from Catalu~na, 23 from Andalucıa, 18 from Extremadura, 13 from Navarra and 11
from Castilla la Mancha.
(b): Twenty-three farmers were from Alentejo, 15 from Lisbon, 8 from Central and 3 from North.
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selected from the sampling frame should be included in the report, including, where relevant,
the statistical software and/or the program code used for this procedure. The proportion of
farmers cultivating maize MON 810 for the ﬁrst time and of farmers with previous experience of
maize MON 810 selected from the sampling frame in each region should be presented in the
monitoring report in order to provide evidence that the sampling method ensures that areas of
intensive maize MON 810 cultivation are appropriately covered by the survey.
• The questionnaire relies on a comparison between a representative GM maize ﬁeld and a
representative conventional ﬁeld in order to detect unanticipated adverse effects.
Consequently, the choice of representative ﬁelds and the recollection of similarities and
differences are crucial to the success of the survey. The questionnaire provides a list of the GM
and non-GM varieties grown by each farmer, but it is unclear which conventional and GM ﬁelds
have been actually compared. The farmer questionnaire should be more speciﬁc on the
comparison that has been made. If no comparators are being grown spatially or temporally
close to the GM crop, then the rationale for selecting another comparator (e.g. maize grown in
previous years) should be fully described. The speciﬁc comparators selected by the farmers for
the survey should also be summarised in the monitoring report.
• Farmer questionnaires should focus only on changes that would be recognised by the farmer
during the daily management of the farm. However, additional questions could be included to
gain a better understanding of the intensity of GM maize cultivation on the farm (number of
years of maize MON 810 cultivation and frequency of maize MON 810 in crop rotations), and
further information on plant protection product usage (in particular, in the comparator ﬁeld)
should be obtained to facilitate a full understanding of any observed changes.
Moreover, qualitative responses may sometimes relate to a subjective assessment on the part
of the farmer. An effort should be made to use objective measurable outcomes, whenever this
is possible. In addition, the possible answers to the question concerning the insect pest control
(for the two corn borers) in the MON 810 maize compared to the conventional maize are ‘very
good’, ‘good’, ‘weak’ and ‘don’t know’. Given that the question requests again a comparison
with the conventional maize, this set of possible responses does not appear to be appropriate.
It should be ensured that the interpretation of each of the offered response options is clear to
the farmers and some relevant information should also be offered in the survey report. Based
on the information provided in the report, it is not clear how exactly these response options
were interpreted by the farmers, especially the option ‘good’ which has been indicated by
4.2% of the surveyed farmers for each of the two borers in the 2015 farmer questionnaire
survey. No statistical tests have been presented for these variables.
• Focusing on the analysis of the data from the questionnaires included in the 2015 PMEM
report, a similar comment as last year concerning the overall type I error in the statistical
comparisons is warranted. The choice of statistical test should be based on the number of
possible outcomes, since the use of a series of binomial tests for multinomial distributions
would increase the experiment-wise Type I error rate (i.e. failure to detect a true adverse
effect). In the current analysis, a closed principle test procedure is proposed to be used in
order to address the issue of the overall type I error. This approach is acceptable, and can be
effective for this purpose, if applied correctly, with the relevant not ‘as usual’ effects being
assessed only when the null hypothesis pAs usual ≤ 0.9 is not rejected. However, in practice, in
the monitoring characteristics comparisons presented in the 2015 PMEM report (table 5 of
Appendix 1), the results of all possible tests are presented, when in the ﬁrst hypothesis test
the null hypothesis pAs usual ≤ 0.9 is not rejected. Therefore, in the current report whenever
the pAs usual ≤ 0.9 hypothesis is rejected, the decision is based only on this outcome. When this
hypothesis is not rejected then, in the case of questions with three possible responses, two
additional tests (for the probabilities of Plus- and Minus-answers) are being conducted, and
therefore, some correction for the overall type-I error rate is still necessary.
• The GMO Panel considers that the sample size calculation provided in Annex I of the 2015
PMEM report indicates that the pre-set requirements (including the achievement of the pre-
speciﬁed power) would be satisﬁed with a sample size of 2,500 questionnaires. Moreover, the
statistical analysis should be planned to allow an analysis of the monitoring characteristics
according to the length of GM crop cultivation in order to assess residual effects and possible
trends. Certain effects may reach a sufﬁcient magnitude for detection only with repeated
cultivation of a GM crop, and so amendments to study design and the analysis plan should be
considered in order to assess the effect of multiple years of GM crop cultivation. For all these
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reasons, and also in order to achieve the statistical power described in the sample size
calculations, the analysis needs to be pooled after 10 years. The 2015 PMEM report represents
the 10th year report, but a pooled analysis of all the data of the 10 years was not provided.
Therefore, the GMO Panel recommends that the analysis should be pooled at this 10-year
period and analysis of the combined data sets is carried out. In such an analysis, consideration
should be given to the consistency of questions to assess monitoring characteristics and the
comparability of the obtained data from year to year, the possible inclusion of the same
farmers in more than one year in the survey (and the enumeration of these farmers in the
report) and the interim analyses performed for the annual reports.
3.3.1. Conclusions on farmer questionnaires
The consent holder reported that the analysis of the 2015 farmer questionnaires on maize
MON 810 did not show any unanticipated adverse effects related to MON 810 plants and their
cultivation.
The GMO Panel notes that in the 2015 PMEM report of maize MON 810 it is stated that 2,627
questionnaires have been completed over 10 years since the ﬁrst questionnaires were conducted in
2006. A sample size of 2,500 has been determined by the consent holder (EFSA GMO Panel, 2011a)
deemed necessary to achieve sufﬁcient power to identify unanticipated adverse effects caused by
maize MON 810. In its scientiﬁc opinion on the 2014 PMEM report of maize MON 810 (EFSA GMO
Panel, 2016), the GMO Panel strongly recommended the consent holder to perform statistical analyses
pooling all the data from the surveys obtained over the last 10 years and report the results of these
analyses in the annual 2015 PMEM report. On 17 January 2017, the GMO panel invited the consent
holder to submit such analysis for assessment by risk managers and EFSA. The consent holder
informed on 6 February 2017 that the analysis with the pooled data has not been included in the 2015
PMEM report as Monsanto’s intention is to publish the results in a peer-reviewed journal. The GMO
Panel is of the opinion that the assessment of the results of the 10-year analysis is needed in order to
evaluate the farmer questionnaire methodology for the detection of unintended effects caused by the
cultivation of maize MON 810.
3.4. Existing monitoring networks
Directive 2001/18/EC and Council Decision 2002/811/EC propose to make use of existing
monitoring networks, as such networks can complement farmer questionnaires and provide an
additional tool for the GS of GM plants. Member States have various networks in place – some of
which have a long history of data collection – that may be helpful in the context of GS of GM plants.
The networks involved in routine monitoring offer recognised expertise in a speciﬁc domain and have
the tools to capture information on important environmental aspects over a large geographical area.
As in previous annual PMEM reports, the consent holder did not report information gathered by
existing monitoring networks in the EU. However, the GMO Panel notes that efforts have been made to
develop a methodological framework to facilitate the use of existing networks in the broader context of
environmental monitoring (Centre for Ecology and Hydrology, Perseus et al., 2014; EFSA GMO Panel,
2014b; Smets et al., 2014). The GMO Panel encourages that these efforts are continued by relevant
parties (EFSA GMO Panel, 2011b).
3.5. Literature searching
3.5.1. Relevant scientiﬁc studies reported by the consent holder
The consent holder performed a literature search to identify studies on maize MON 810 and Cry1Ab
that were published in the peer-reviewed scientiﬁc literature between June 2015 and May 2016.
The consent holder used the databases Web of Science Core Collection27 and CABI CAB
Abstracts28 to identify relevant studies. The scientiﬁc literature search conducted in the Web of
Science Core Collection database was conducted every month, covering the period of June 2015 to
May 2016. The single search performed in the CABI CAB Abstracts database was performed on
27 May 2016.
27 http://thomsonreuters.com/en/products-services/scholarly-scientific-research/scholarly-search-and-discovery/web-of-science-
core-collection.html (Accessed 19 April 2017).
28 http://www.cabi.org/publishing-products/online-information-resources/cab-abstracts/ (Accessed 19 April 2017).
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The search strategy29 used for the literature search was similar to that applied in the search
reported in the previous annual PMEM report (for further details see EFSA GMO Panel, 2016).
The consent holder deﬁned a priori eligibility/inclusion criteria to categorise the relevance of
retrieved studies. Studies pertaining to a category related to the risk assessment of maize MON 810
were considered relevant.
After applying the eligibility/inclusion criteria, the consent holder identiﬁed 18 relevant primary
research studies (hereafter referred to as publications) published between June 2015 and May 2016
(Appendix D). Five publications were relevant for the food and feed (FF) safety assessment (in terms
of toxicity and allergenicity), 13 publications pertained to the ERA or the IRM of maize MON 810 (most
studies assessed the interaction of maize MON 810 with target organisms and non-target organisms).
Three of the 18 publications, B€ottger et al. (2015), Holderbaum et al. (2015) and Xu et al. (2015),
have already been assessed by EFSA (EFSA, 2016b) or the GMO Panel (EFSA GMO Panel, 2016), and
have concluded that no environmental safety concerns owing to maize MON 810 and Cry1Ab were
identiﬁed.
GMO Panel assessment
The GMO Panel acknowledges that the consent holder has revised the protocol for the literature
search accounting for the EFSA guidance on systematic review methodology (EFSA, 2010) and
previous GMO Panel recommendations on literature searching performed in the context of PMEM
reports (i.e. report the dates of the search, use of a second database, report the eligibility/inclusion
criteria for relevance, and provide the full list of retrieved publications) (EFSA GMO Panel, 2016).
However, the GMO Panel still considers that the consent holder should: (i) better deﬁne the review
question, including its key elements, and its purpose; (ii) better report the results of the literature
search; in particular, the number of scientiﬁc publications retrieved from each database, the number
and list of publications remaining after removing duplicates, and the number of publications that were
considered not relevant based on title and abstract on each of the steps of the searching process; and
(iii) detail how the selection of relevant publications was conducted, provide the reason(s) for
categorising each publication as not relevant, and report which of the relevant publications were
previously risk assessed by EFSA.
The GMO Panel assessed all the scientiﬁc publications selected by the consent holder, and considers
that these were adequately discussed and put into the context of the overall safety assessment of
maize MON 810. The GMO Panel did not identify food/feed or environmental safety concerns
pertaining to maize MON 810 or Cry1Ab from any the publications.
The ﬁndings of one publication conﬁrms that, in addition to the target species, some regionally
important lepidopteran pests, such as Mythimna unipuncta (Lepidoptera: Noctuidae), exposed to
Lepidoptera-active Bt-maize events may also have the potential to evolve resistance to Cry1 proteins
(Garcıa et al., 2015), and therefore, they should be considered within the PMEM of maize MON 810.
For some of these regionally important lepidopteran pests, the Cry1Ab protein might not be expressed
in relevant plant tissues at high toxic concentrations, meaning that one of the underlying assumptions
contributing to the success of the ‘high-dose/refuge’ strategy in delaying resistance evolution is not
fulﬁlled (EFSA, 2009). However, the likelihood of regionally occurring non-target lepidopteran pests to
evolve resistance is lower than that of target pests due to the lower exposure and, therefore, routine
insect resistance monitoring would not be proportionate at this time. Instead, GS through farmer
questionnaires and/or literature searching is currently used to report information on the occurrence of
regionally important lepidopteran pests other than ECB and MCB, and the occurrence of damaged
maize MON 810 plants. Outbreaks of regionally important lepidopteran pests should trigger subsequent
investigations, including CSM if necessary.
3.5.2. Conclusions on literature searching
The results reported in the relevant peer-reviewed scientiﬁc studies identiﬁed and considered by the
consent holder in its 2015 PMEM report do not provide new information that would invalidate the
previous FF and ERA conclusions on maize MON 810 made by the GMO Panel.
For future literature searches performed in the context of the 2016 PMEM report, the GMO
Panel recommends the consent holder to follow the recommendations given in the EFSA’s explanatory
note to the guidance on literature searching (EFSA, 2017).
29 The search strategy used to identify relevant scientiﬁc publications is given in Table 1 of the 2015 PMEM report.
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4. Conclusions
The data reported in the 2015 PMEM report do not indicate any adverse effects on human and
animal health or the environment arising from the cultivation of maize MON 810 during the 2015
growing season. The GMO Panel therefore concludes that the CSM and GS activities of maize MON 810
as carried out by the consent holder do not provide evidence that would invalidate previous GMO
Panel evaluations on the safety of maize MON 810 (EFSA, 2009; EFSA GMO Panel, 2012b,c). However,
the GMO Panel identiﬁed methodological limitations pertaining to insect resistance monitoring and
farmer questionnaires that need further consideration by the consent holder, because the resistance
monitoring activities do not provide sufﬁcient sensitivity for an early detection of potential resistance of
target pests in the ﬁeld, and the sampling frame for the farmer questionnaires does not allow the
assessment of the representativeness of the results.
5. Recommendations
5.1. Case-speciﬁc monitoring
The GMO Panel considers that the detection levels of resistance allele frequency in target pest
populations set by risk managers should provide sufﬁcient time to implement appropriate mitigation
measures to prevent ﬁeld resistance. Therefore, the GMO Panel reiterates its previous recommendation
that a threshold of 3% should be achieved in practice. The GMO Panel notes that the monitoring
protocol adopted does not provide the sufﬁcient sensitivity to detect early cases of resistance, and
urges the consent holder to increase sampling efforts and ensure that as many ﬁeld-collected larvae as
possible are represented in the laboratory assays as F1 larvae.
The GMO Panel has previously recommended focusing the monitoring activities in north-east Iberia
(i.e. the Ebro valley), where ﬁeld resistance to Cry1Ab is more likely to develop. In that geographical
area, insects should be collected annually from three sampling zones of approximately 10 km 9 10 km
where adoption rate of maize MON 810 has been higher than 60% for at least three consecutive
years. In order to acquire this information, non-GM and maize MON 810 cropping areas at an
appropriate scale should be made available by Member States.
For future PMEM reports, the GMO Panel recommends the consent holder:
• to provide both LC and MIC values and their 95% CI, for ECB and MCB ﬁeld populations and
their reference laboratory strains;
• to calculate RR for ECB by dividing the MIC50,90 of the ﬁeld-collected population by the
MIC50,90 of the respective laboratory reference strain;
• to include a negative control (i.e. larvae fed with near-isogenic maize leaves) and provide
further information (e.g. LT50, developmental stage at death, Cry1Ab protein expression in
detached leaves) in the conﬁrmatory experiment with maize MON 810 leaves so that these
conﬁrmatory tests can be appropriately assessed, and thus used to reinforce the bioassays
with puriﬁed Cry1Ab;
• to collect individuals from areas where Cry1-expressing maize is not grown when refreshing
the reference laboratory strains so that newly individuals have not been subjected to selection
pressure;
• to disclose the raw data of insect bioassays to (1) evaluate and verify the quality of the data;
and (2) to assess the analysis of such assays.
The GMO Panel considers that the consent holder should provide more information on the farmer
alert system in order to appraise its usefulness as complementary resistance monitoring tool, and
determine whether appropriate communication mechanisms and ﬁt-for-purpose educational programs
are implemented that ensure the timely and effective reporting of farmer complaints. Considering the
implementation of non-Bt-refuges, the GMO Panel reiterates that the consent holder should pursue its
efforts to further increase the level of compliance, especially in regions of high maize MON 810
adoption.
5.2. General surveillance
The GMO Panel identiﬁed shortcomings in the methodology followed by the consent holder to
analyse the farmer questionnaires similar to those found in previous reports. Therefore, the GMO
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Panel reiterates its recommendations on the survey design and reporting to provide more detailed
information on the sampling methodology and to reduce the possibility of selection bias, as this would
give more conﬁdence in the conclusion on the absence of adverse effects. In order to improve the
sampling frame of the farmer survey, the GMO Panel reiterates the importance of national GMO
cultivation registers and its recommendations to consent holders to consider how they may make best
use of the information recorded in national registers and foster dialogue with those responsible for the
administration of the registers of maize MON 810 cultivation. The GMO Panel recommends the
applicant to provide the pooled analysis from the surveys obtained over the last ten years in order to
(1) conﬁrm that no unintended effects caused by the cultivation of maize MON 810 have been
observed; and (2) to evaluate the farmer questionnaire methodology for the detection of unintended
effects caused by the cultivation of maize MON 810.
No information collected from existing monitoring networks in the EU was provided by the consent
holder. However, the GMO Panel notes that initiatives have been taken to develop a methodological
framework to use existing networks in the broader context of environmental monitoring, and
encourages the relevant parties to continue to develop these.
Regarding the protocol for the literature search, the GMO Panel makes recommends the consent
holder:
• to better deﬁne the review question, including its key elements, and its purpose;
• to better report the results of the literature search; in particular, the number of scientiﬁc
publications retrieved from each database, the number and list of publications remaining after
removing duplicates, and the number of publications that were considered not relevant based
on title and abstract on each of the steps of the searching process;
• to detail how the selection of relevant publications was conducted, provide the reason(s) for
categorising each publication as not relevant, and report which of the relevant publications
were previously risk assessed by EFSA.
For future literature searches, the GMO Panel recommends the consent holder to follow the
recommendations given in the EFSA’s explanatory note to the guidance on literature searching (EFSA
et al., 2017).
Documentation provided to EFSA
1) Letter from the European Commission, dated 12 October 2016, to EFSA requesting the
assessment of the annual PMEM report on the cultivation of maize MON 810 during the 2015
season (2015 PMEM report) provided by Monsanto; the PMEM report was annexed to the
letter.
2) Comments from the Member States on the 2015 PMEM report.
3) Acknowledgment letter dated 30 November 2016 from EFSA to the European Commission.
4) Letter from the European Commission, dated 17 January 2016, to the consent holder
requesting additional information.
5) Letter from the European Commission, dated 20 March 2017, to EFSA requesting to take into
account the updated version of the 2015 PMEM report.
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Abbreviations
AMU Assessment and Methodological Support Unit
Bt Bacillus thuringiensis
CI conﬁdence interval
CSM case-speciﬁc monitoring
ECB European corn borer
ERA environmental risk assessment
FF food and feed
GM genetically modiﬁed
GMO genetically modiﬁed organism
GMO Panel EFSA Panel on Genetically Modiﬁed Organisms
GS general surveillance
IRM insect resistance management
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LC lethal concentration
LT lethal time
MCB Mediterranean corn borer
MIC moulting inhibition concentration
PMEM post-market environmental monitoring
RR resistance ratio
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Appendix A – Compliance with refuge requirements by Spanish farmers
between 2009 and 2015 from two sources
Growing
season
No. farmers
surveyed
No. farmers
planting
refuges
No. farmers not
planting refuges Compliance
(%)(a)
Source(b)
Field
< 5 ha(a)
Field
> 5 ha
2006 100 56 27 17 77 FQ
100 64 0 36 64 Antama
2007 100 70 9 21 77 FQ
100 60 0 40 60 Antama
2008 99 76 10 13 85 FQ
100 82 0 18 82 Antama
2009 100 85 7 8 91 FQ
100 81 0 19 81 Antama
2010 150 129 8 13 91 FQ
100 88 NR NR >88 Antama
2011 150 134 10 6 96 FQ
100 93 NR NR >93 Antama
2012 175 130 21 24 84 FQ
110 NR NR NR ≥93 Antama
2013 190 153 15 22 87 FQ
2014 213 178 24 11 94 FQ
2015 212 162 38 12 93 FQ
NR: not reported.
(a): Farmers planting < 5 ha of maize MON 810 in the farm are not required to plant a refuge. For the FQ, only farmers who
were required to plant a refuge were considered for the calculation of non-compliance with refuge requirements.
(b): FQ: farmer questionnaires; Antama: Study sponsored by Spanish foundation supporting the use of new technologies in
agriculture. In the surveys conducted by Antama all farmers were from the Ebro valley (Spain).
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Appendix B – Area and adoption rate of maize MON 810 in the north-east
Iberia (Aragon and Catalu~na), central Iberia (Albacete) and south-west
Iberia (Extremadura and Andalucıa) between 2011 and 2015 recorded by
two sources
Season
Area maize
MON 810 (ha)(a)
Source
Avances(b) ESYRCE(c)
Total
maize (ha)
Adoption
rate (%)
Total
maize (ha)
Adoption
rate (%)
North-east Iberia
2011 71,000 113,299 62.7 125,297 56.7
2012 75,200 108,621 69.2 107,564(d) 69.9
2013 88,447 125,293 70.6 119,859(d) 73.8
2014 90,422 128,959 70.1 141,218 64.0
2015 73,402 121,758(e) 60.3 113,380(d) 64.7
2011–2015 – – 66.6 – 65.8
Central Iberia
2011 5,041 15,718 32.1 15,967(d) 31.6
2012 6,453 17,701 36.5 19,297(d) 33.4
2013 6,564 16,950 38.7 20,698(d) 31.7
2014 5,696 14,700 38.8 16,585(d) 34.3
2015 4,027 9,300(e) 43.3 14,895(d) 27.0
2011–2015 – – 37.9 – 31.6
South-west Iberia
2011 15,811 85,295 18.5 94,621 16.7
2012 26,313 101,649 25.9 118,039(d) 22.3
2013 31,058 113,437 27.4 123,097(d) 25.2
2014 24,507 96,999 25.3 108,574 22.6
2015 21,298 87,212(e) 24.4 100,210(d) 21.3
2011–2015 – – 24.3 – 21.6
NA: not available.
(a): Source: http://www.magrama.gob.es/es/calidad-y-evaluacion-ambiental/temas/biotecnologia/organismos-modificados-gene
ticamente-omg-/consejo-interministerial-de-ogms/superficie.aspx (Accessed 19 April 2017).
(b): Avances de superﬁcies y producciones de cultivos: http://www.magrama.gob.es/es/estadistica/temas/estadisticas-agrarias/
agricultura/avances-superficies-producciones-agricolas/ (Accessed 19 April 2017).
(c): Encuesta sobre superﬁcies y rendimiento de cultivos (ESYRCE): http://www.magrama.gob.es/es/estadistica/temas/estadistica
s-agrarias/agricultura/esyrce/ (Accessed 19 April 2017).
(d): Data for maize as a second crop are not included.
(e): Provisional data.
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Appendix C – Susceptibility to puriﬁed Cry1Ab protein of the laboratory
reference strains of Ostrinia nubilalis (ECB) and Sesamia nonagrioides
(MCB)
Target pest (strain) Season Protein batch MIC50 (95% CI)
(a) MIC90 (95% CI)
(a)
ECB (G.04)(b) 2006 1 1.20 (0.50–2.21) 4.78 (2.57–14.38)
2007 1 1.44 (0.86–2.06) 3.94 (2.68–8.28)
2008 1 2.21 (1.89–2.55) 4.47 (3.70–6.00)
2008 1 2.26 (1.49–3.01) 8.16 (5.95–13.50)
2009 1 3.65 (2.77–4.90) 9.56 (6.72–17.75)
2010 1 2.77 (2.22–3.27) 6.03 (4.93–8.41)
2011 1 4.01 (2.58–6.12) 10.07 (6.50–28.96)
2011 2 2.94 (2.33–3.60) 6.27 (4.97–8.91)
2012 2 0.37 (0.14–0.62) 1.13 (0.67–6.39)
2013 2 1.97 (0.78–5.59) 5.66 (2.67–95.34)
2013 2a 1.96 (0.84–4.60) 6.57 (3.13–50.53)
2014 2a 0.28 (0.24–0.33) 0.46 (0.38–0.62)
2015 2a 4.03 (2.85–4.86) 7.03 (5.83–9.91)
ECB (ES.ref)(c) 2015 2a 1.82 (1.53–2.16) 2.95 (2.43–4.54)
MCB(d) 2004 B1 18 (11–25) 99 (66–208)
2007 B1 16 (11–22) 94 (69–147)
2008/2009 B1 19 (10–30) 120 (76–255)
2010 B1 8 (5–11) 74 (51–117)
2011 B2 9 (6–13) 68 (45–127)
2012 B2 7 (5–10) 62 (41–107)
2013 B2 7 (5–10) 48 (31–88)
2013 B3 5 (3–9) 42 (26–87)
2014 B3 17 (11–25) 91 (57–209)
2015 B3 28 (21–36) 67 (50–110)
(a): 50% and 90% moulting inhibition concentration (MIC50 and MIC90) and their 95% conﬁdence intervals (CI 95%) are
expressed in ng Cry1Ab/cm2.
(b): The G.04 strain was established from ECB larvae collected from Niedernberg (Germany) in 2002. This strain has never been
refreshed with ﬁeld-collected individuals.
(c): The ES.ref strain was established from 145 ECB diapausing larvae collected from three sampling sites in Galicia (Spain) in
2015, of which 75 survived the diapause, reached the adult stage and mated.
(d): The MCB strain was established from larvae collected from Andalucıa (661 larvae), Madrid (793 larvae), Ebro (857 larvae),
and Galicia (665 larvae) (Spain) in 1998 (Gonzalez-Nu~nez et al., 2000). To preserve its vigour, the MCB strain is refreshed
periodically with new individuals. To this end, the progenies of the populations collected for the monitoring bioassays are
used, and between 10 and 15% of new individuals with respect to the laboratory strain are introduced.
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